Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

Similar articles for PubMed (Select 23145869)

1.

Clinical usefulness of (18) F-fluorodeoxyglucose positron emission tomography/computed tomography for patients with primary liver cancer with special reference to rare histological types, hepatocellular carcinoma with sarcomatous change and combined hepatocellular and cholangiocarcinoma.

Ijichi H, Shirabe K, Taketomi A, Yoshizumi T, Ikegami T, Mano Y, Aishima S, Abe K, Honda H, Maehara Y.

Hepatol Res. 2013 May;43(5):481-7. doi: 10.1111/j.1872-034X.2012.01107.x. Epub 2012 Nov 12.

PMID:
23145869
2.

Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade.

Wolfort RM, Papillion PW, Turnage RH, Lillien DL, Ramaswamy MR, Zibari GB.

Int Surg. 2010 Jan-Mar;95(1):67-75.

PMID:
20480845
4.

Can positron emission tomography with the dual tracers [11 C]acetate and [18 F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma?

Cheung TT, Chan SC, Ho CL, Chok KS, Chan AC, Sharr WW, Ng KK, Poon RT, Lo CM, Fan ST.

Liver Transpl. 2011 Oct;17(10):1218-25. doi: 10.1002/lt.22362.

5.

Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma.

Lee JW, Paeng JC, Kang KW, Kwon HW, Suh KS, Chung JK, Lee MC, Lee DS.

J Nucl Med. 2009 May;50(5):682-7. doi: 10.2967/jnumed.108.060574. Epub 2009 Apr 16.

6.

Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.

Zuo HQ, Yan LN, Zeng Y, Yang JY, Luo HZ, Liu JW, Zhou LX.

Hepatobiliary Pancreat Dis Int. 2007 Apr;6(2):161-5.

7.

A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.

Park JW, Kim JH, Kim SK, Kang KW, Park KW, Choi JI, Lee WJ, Kim CM, Nam BH.

J Nucl Med. 2008 Dec;49(12):1912-21. doi: 10.2967/jnumed.108.055087. Epub 2008 Nov 7.

8.

Clinical value of pre-and postoperative 18F-FDG PET/CT in patients undergoing liver transplantation for hepatocellular carcinoma.

Wang XL, Li H, Wang QS, Zhang XL.

Nan Fang Yi Ke Da Xue Xue Bao. 2006 Aug;26(8):1087-91, 1095.

9.

Preoperative risk stratification using (18)F-FDG PET/CT in women with endometrial cancer.

Lee HJ, Ahn BC, Hong CM, Song BI, Kim HW, Kang S, Jeong SY, Lee SW, Lee J.

Nuklearmedizin. 2011;50(5):204-13. doi: 10.3413/nukmed-0375-10-12. Epub 2011 Jul 5.

PMID:
21727990
10.

Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.

Trojan J, Schroeder O, Raedle J, Baum RP, Herrmann G, Jacobi V, Zeuzem S.

Am J Gastroenterol. 1999 Nov;94(11):3314-9.

PMID:
10566736
11.

Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases.

Yano Y, Yamamoto J, Kosuge T, Sakamoto Y, Yamasaki S, Shimada K, Ojima H, Sakamoto M, Takayama T, Makuuchi M.

Jpn J Clin Oncol. 2003 Jun;33(6):283-7.

12.

Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.

Yin X, Zhang BH, Qiu SJ, Ren ZG, Zhou J, Chen XH, Zhou Y, Fan J.

Ann Surg Oncol. 2012 Sep;19(9):2869-76. doi: 10.1245/s10434-012-2328-0. Epub 2012 Mar 27.

PMID:
22451237
13.

Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma.

Tang D, Nagano H, Nakamura M, Wada H, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Dono K, Monden M.

J Gastrointest Surg. 2006 Jul-Aug;10(7):987-98.

PMID:
16843869
14.

[Diagnostic accuracy of 18F-FDG positron emission tomography for evaluation of hepatocellular carcinoma].

Shin JA, Park JW, An M, Choi JI, Kim SH, Kim SK, Lee WJ, Park SJ, Hong EK, Kim CM.

Korean J Hepatol. 2006 Dec;12(4):546-52. Korean.

15.

The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients.

Yang SH, Suh KS, Lee HW, Cho EH, Cho JY, Cho YB, Yi NJ, Lee KU.

Liver Transpl. 2006 Nov;12(11):1655-60. Erratum in: Liver Transpl. 2007 Jan;13(1):175.

16.

Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.

Kim YK, Lee KW, Cho SY, Han SS, Kim SH, Kim SK, Park SJ.

Liver Transpl. 2010 Jun;16(6):767-72. doi: 10.1002/lt.22069.

17.

Prognosis of hepatocellular carcinoma expressing cytokeratin 19: comparison with other liver cancers.

Lee JI, Lee JW, Kim JM, Kim JK, Chung HJ, Kim YS.

World J Gastroenterol. 2012 Sep 14;18(34):4751-7.

18.

Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma.

Groeschl RT, Turaga KK, Gamblin TC.

J Surg Oncol. 2013 May;107(6):608-12. doi: 10.1002/jso.23289. Epub 2013 Feb 5.

PMID:
23386397
19.

Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors.

Iwata Y, Shiomi S, Sasaki N, Jomura H, Nishiguchi S, Seki S, Kawabe J, Ochi H.

Ann Nucl Med. 2000 Apr;14(2):121-6.

PMID:
10830530
20.

Increased 18F-FDG uptake of hepatocellular carcinoma on positron emission tomography independently predicts tumor recurrence in liver transplant patients.

Kornberg A, K├╝pper B, Thrum K, Katenkamp K, Steenbeck J, Sappler A, Habrecht O, Gottschild D.

Transplant Proc. 2009 Jul-Aug;41(6):2561-3. doi: 10.1016/j.transproceed.2009.06.115.

PMID:
19715974
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk